Showing results (441-450 of 454) with videos related to
Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|May 20, 2015
9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitorsKurt Zimmermann, Xiaopeng Sang, Harold A Mastalerz, et al.Journal of Hospital Medicine|October 16, 2012
Prospective comparison of curbside versus formal consultationsMarisha Burden, Ellen Sarcone, Angela Keniston, et al.Postepy Dermatologii I Alergologii|November 26, 2020
Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family MedicineRoman J Nowicki, Magdalena Trzeciak, Lidia Rudnicka, et al.Bioorganic & Medicinal Chemistry Letters|July 4, 2007
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.Journal of AOAC International|October 20, 2017
Evaluation of <i>mericon E. coli</i> O157 Screen Plus and <i>mericon E. coli</i> STEC O-Type Pathogen Detection Assays in Select Foods: Collaborative Study, First Action 2017.05Patrick Bird, M Joseph Benzinger, Benjamin Bastin, et al.Postepy Dermatologii I Alergologii|May 30, 2020
Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment and phototherapyRoman J Nowicki, Magdalena Trzeciak, Maciej Kaczmarski, et al.Postepy Dermatologii I Alergologii|June 4, 2020
Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new therapeutic methodsRoman J Nowicki, Magdalena Trzeciak, Maciej Kaczmarski, et al.Scientific Reports|May 11, 2026
Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosisMarie Zöller, Michal Mastalerz, Elisabeth Dick, et al.Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.Pageof 46